Mithra Granted EUR 1.9 million in Non-Dilutive Funding

  • Non-dilutive funding granted by the Walloon region
  • Funding to support Estetrol (E4) and complex therapeutics solutions research projects

Liège, Belgium, 13 February 2017, 07.30am CET – Mithra Pharmaceuticals (Euronext Brussels: MITRA), a company focused on women’s health, today announces that it has been granted EUR 1.9 million in non-dilutive funding from the Walloon Region. The grant follows a decision by the Vice-President and Minister for Economy, Industry, Innovation and New Technologies, Mr Jean-Claude Marcourt.